Equities

Covalon Technologies Ltd

COV:CVE

Covalon Technologies Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CAD)1.99
  • Today's Change0.01 / 0.51%
  • Shares traded4.30k
  • 1 Year change+2.58%
  • Beta0.6740
Data delayed at least 15 minutes, as of Jun 14 2024 20:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.

  • Revenue in CAD (TTM)26.24m
  • Net income in CAD-2.77m
  • Incorporated2004
  • Employees--
  • Location
    Covalon Technologies Ltd1660 Tech Avenue, Unit 5MISSISSAUGA L4W 5S7CanadaCAN
  • Phone+1 (905) 568-8400
  • Fax+1 (905) 568-8400
  • Websitehttps://covalon.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medexus Pharmaceuticals Inc158.95m8.08m37.91m98.004.240.93372.350.23850.36590.36597.311.660.75472.195.441,621,921.003.83-6.838.44-9.7952.9153.905.08-11.450.70130.94260.6388--40.9369.17142.41---8.59--
Immunoprecise Antibodies Ltd23.69m-14.27m37.97m102.00--0.7618--1.60-0.4121-0.41210.68321.380.29395.256.76169,018.60-17.70-23.62-19.62-27.2551.8857.18-60.23-76.181.38--0.2241--6.7230.59-58.96--34.04--
Eastwood Bio-Medical Canada Inc736.75k-531.60k41.33m--------56.10-0.0077-0.00770.0107-0.0131.63--38.65---117.75-52.23---140.2960.0052.09-72.15-52.90---227.16-----33.223.13-264.69------
IntelGenx Technologies Corp.1.44m-15.15m41.92m48.00------29.04-0.0868-0.08680.0083-0.12080.124514.361.74---130.62-75.15---133.79-66.03---1,049.48-819.850.1153-4.8823.66--9.37-10.657.14---30.32--
Microbix Biosystems Inc23.84m4.06m44.50m69.0010.991.618.151.870.02960.02960.1730.2020.67031.676.33--11.42-0.972912.72-1.1754.3852.3017.04-1.554.983.530.1948---13.435.71-102.21---3.56--
MustGrow Biologics Corp4.71m-665.06k47.18m0.00--10.42--10.01-0.0134-0.01340.09360.09120.7632--45.31---10.77-50.41-14.00-59.28-----14.11-298.73----0.1393--72,619.13372.5487.84------
Covalon Technologies Ltd26.24m-2.77m49.88m----2.48--1.90-0.1123-0.11231.060.80211.021.844.53---10.83-18.06-12.67-27.1055.8451.89-10.57-27.064.85--0.0597--46.56-0.09651.79--12.21--
KDA Group Inc186.28k133.66k49.99m--141.793.2257.22268.350.0020.09260.00120.08860.0079--0.0693---0.4146-17.96-0.8534-44.6936.5126.76-52.24-28.00---4.310.1287---22.20-62.03106.88--31.67--
LSL Pharma Group Inc12.17m-4.62m51.84m----3.22--4.26-0.056-0.0560.14660.14890.39292.594.87---14.92---21.69--19.76---37.97--0.4505-0.84650.4938--------------
Helix Biopharma Corp.0.00-5.65m58.83m9.00---------0.0277-0.02770.00-0.00120.00----0.00-318.95-261.49-574.76-------------2,825.00--------4.16---28.36--
Simply Better Brands Corp95.08m-30.01m59.65m--------0.6274-0.4156-0.43051.32-0.08542.7112.6817.69---85.10-63.90-361.23-215.4853.52---31.40-29.460.2536-19.653.20--22.08---96.41------
Satellos Bioscience Inc0.00-21.13m60.91m12.00--1.77-----0.1718-0.17180.000.30590.00----0.00-93.29-107.22-109.86-136.58------------0.00-------40.33--459.46--
Data as of Jun 14 2024. Currency figures normalised to Covalon Technologies Ltd's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.